The low-molecular-weight heparin, nadroparin, inhibits tumour angiogenesis in a rodent dorsal skinfold chamber model

BACKGROUND: Recently, low-molecular-weight heparins (LMWHs) were found to confer a survival advantage in cancer patients. The mechanism underlying this observation is unclear, but may involve inhibition of tumour angiogenesis. We aimed to examine the effects of nadroparin on tumour angiogenesis usin...

Descripción completa

Detalles Bibliográficos
Autores principales: Debergh, I, Van Damme, N, Pattyn, P, Peeters, M, Ceelen, W P
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2010
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833243/
https://www.ncbi.nlm.nih.gov/pubmed/20125158
http://dx.doi.org/10.1038/sj.bjc.6605535

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833243/
https://www.ncbi.nlm.nih.gov/pubmed/20125158
http://dx.doi.org/10.1038/sj.bjc.6605535

Ejemplares similares